Getting paid: Here’s why your drug screen tests were denied: A Medicare claims hold

Subscribe or sign in to view the full article.

Note:  The following article synopsis was NOT provided by HCPro. It was created by Find-A-Code/innoviHealth.

Article Overview

This article explains a Medicare claims processing issue affecting drug screen test claims and reviews the broader 2016 shift in drug testing code selection. It is aimed at coders, billing staff, laboratory teams, and practices that bill drug screening services to Medicare or commercial payers. The discussion covers temporary claim adjudication problems, changes in presumptive and definitive drug testing code selection, and the need to monitor private payer coding preferences.

Why This Topic Matters

Drug screening claims can be denied or delayed if the wrong code set or modifier is used, and payer policies may differ. The article helps billing teams understand why claims may be held, what broad coding changes are involved, and why payer follow-up matters.

Article Sections

  1. Medicare claims hold and system issue

    Explains a temporary Medicare processing problem affecting drug screen claims and the related timing of claim adjudication changes.

  2. Select new codes based on type of test

    Introduces the 2016 drug screen code changes and compares broad categories of test methodology used for code selection.

  3. Expect to see pay drop in 2016

    Discusses general payment changes associated with the updated drug screen code structure and bundled components.

  4. Definitive test coding is class based

    Covers the distinction between definitive testing and other drug testing approaches, including class-based reporting concepts.

  5. Watch your private payers

    Reviews payer variability and the need to verify which drug testing code set different insurers are using.

What You Will Learn

  • How a Medicare claims hold can affect drug screen test billing
  • What broad types of 2016 drug testing code changes were introduced
  • How presumptive and definitive drug testing were being distinguished in the article
  • Why payer-specific coding guidance matters for drug screening claims
  • What kinds of workflow updates practices may need when drug testing codes change

Who Should Read This

  • Medical coders
  • Billing staff
  • Laboratory personnel
  • Pain management practices
  • Physician practices billing drug testing services
  • Revenue cycle teams

Codes Discussed

Code Ranges Discussed

  • HCPCS LEVEL II: G0477-G0483
  • HCPCS LEVEL II: G0431-G0434
  • HCPCS LEVEL II: G6030-G6058

Modifiers Discussed


Subscribe or sign in to view the full article.

Official DecisionHealth® Newsletter Archives includes:

  • Includes over 25,000 articles from:
    • Coder Pink Sheets
    • Part B News
    • Answer Books newsletters
  • Current newsletters added each quarter
  • Timely news and guidance vital for your practice
  • Fully searchable through Find-A-Code's Comprehensive Search
  • Codes mentioned in articles are linked to the Find-A-Code Code Information pages
  • Code Information pages link back to related articles
  • Save yourself tons of research time, find everything in one place!
Access to this feature is available in the following products:
  • DecisionHealth Coding, Billing and Compliance Library

Related Articles

Articles are listed in order of calculated relevance.

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.

Aimee- AI -powered coding assistant - Try it now for Free Would you like Aimee - AI
to help you with this?